Publish Time: 2026-05-22 Origin: Site
China has become one of the most important global hubs for liposome-based raw materials, drug delivery systems, and high-value cosmetic actives, thanks to its mature biotech clusters, competitive costs, and rapidly improving regulatory compliance. For international procurement managers looking for reliable long-term partners, China now offers a full spectrum of suppliers—from pharmaceutical-grade liposome CDMOs to cosmetic and nutraceutical ingredient manufacturers—covering both bulk liposomal actives and highly customized OEM/ODM projects. [sostapi]
Selecting a liposome manufacturer is not just about price; it is about consistency, regulatory robustness, and technical depth, especially when your brand relies on stable efficacy claims and clean-label positioning. [coherentmarketinsights]
Key evaluation dimensions used in this guide:
- Factory certifications and quality systems
International buyers should prioritize suppliers with ISO 9001 or equivalent QMS, food/pharma-grade GMP, and, where relevant, HALAL, KOSHER, and FDA registrations, since these frameworks help ensure batch-to-batch consistency and traceability. [ecocert]
- R&D capabilities and process technology
Leading Chinese liposome manufacturers now deploy microfluidic reactors, high-pressure homogenization, and advanced film hydration systems to keep particle size within a narrow range (often 50–200 nm) and PDI below 0.1, which directly impacts encapsulation efficiency and stability. [sciencedirect]
- QC workflows and analytical infrastructure
Mature factories routinely use TEM, dynamic light scattering, zeta potential measurement, and HPLC/LC-MS to monitor particle morphology, size distribution, encapsulation efficiency, and degradation profiles over stability studies, aligning with global cGMP expectations in nutraceuticals and pharmaceuticals. [pmc.ncbi.nlm.nih]
- Supply reliability and lead-time stability
Export-focused manufacturers in China's key biotech clusters (Xi'an, Shanghai, Jiangsu, Guangdong) have optimized production planning and logistics to serve both bulk shipments and smaller customized batches, making on-time delivery a core competitive metric. [yicaiglobal]
- Regulatory and documentation support
Buyers should assess whether the supplier can provide complete technical dossiers—COA, MSDS, TDS, stability data, ingredient origin declarations, and, where applicable, ISO 16128 natural index or ECOCERT-compatible documentation for cosmetic raw materials. [fdichina]
China's liposome and broader lipid nanoparticle ecosystem has grown rapidly in both drug delivery and functional ingredient segments, covering injectable oncology formulations, oral nutraceuticals, and cosmetic active delivery systems. Industry analyses indicate that Asia-Pacific, with China as a major contributor, now accounts for over one-third of the global lipid nanoparticle market, supported by dense clusters of pharma companies, biotech start-ups, and raw material producers. [linkedin]
On the downstream side, China's cosmetic sector surpassed roughly USD 159.8 billion in 2025, while exports reached about RMB 18.71 billion in the first half of 2025 alone, creating strong domestic demand for advanced delivery systems such as liposomes in skin care, dermocosmetics, and nutricosmetics. This combination of strong internal demand, export growth, and supportive industrial policy has enabled Chinese suppliers to accumulate practical experience across multiple regulatory regimes and product types. [entercogroup]
To build a practical short list for procurement managers, this article integrates public industry rankings, company profiles, and technical disclosures from leading Chinese liposome suppliers. [naturalfieldinc]
The companies included meet most of the following criteria:
- Demonstrated liposome-specific expertise
Each company either manufactures liposomal actives or offers CDMO/CRO services centered on liposome or lipid nanoparticle technologies, rather than being generic chemical traders. [sostapi]
- Export readiness and global customer base
The listed manufacturers typically maintain international certifications, export licenses, and active partnerships with brands or distributors in North America, Europe, or key Asia-Pacific markets. [linkedin]
- Documented QC and process capabilities
Priority is given to suppliers that publicly disclose their QC methodologies, use of nanoscale preparation equipment, and compliance with GMP or equivalent standards. [naturalfieldinc]
- OEM/ODM service depth
For buyers in cosmetics and nutraceuticals, we favor manufacturers that not only sell raw materials but also support formulation co-development, pilot batching, and packaging-ready solutions. [sostapi]
- Balanced portfolio and segment coverage
The final list intentionally balances pharmaceutical-grade, nutraceutical, and cosmetic-oriented liposome suppliers, including at least one high-value yet cost-effective option targeting small and mid-sized brands—where ZHENYIBIO TECHNOLOGY INC fits as a flexible partner. [zhenyibio]
Below is a curated list of ten representative manufacturers, covering pharmaceutical injectables, nutraceutical ingredients, and cosmetic liposomal actives. [coherentmarketinsights]
ZHENYIBIO TECHNOLOGY INC is a high-tech manufacturer specializing in natural plant-derived cosmetic actives and functional raw materials, integrating traditional botanical knowledge with modern biotechnological processes such as fermentation and advanced delivery systems. The company focuses on providing sustainable, science-backed cosmetic ingredients and offers both OEM and ODM services to overseas brands, wholesalers, and manufacturers. [zhenyibio]
For liposome-based cosmetic actives, ZHENYIBIO's core strengths lie in:
- R&D-driven customization
The firm emphasizes collaborative development of plant-based actives in liposomal or related delivery forms, targeting stability, skin penetration, and sensorial compatibility with finished formulations, which is particularly valuable for indie brands and mid-sized labels that need differentiated claims. [xiaoyuzhoufm]
- Flexibility in MOQs and project scope
Unlike large pharma-focused CDMOs, ZHENYIBIO is structurally geared toward small and medium batch runs, pilot projects, and tiered MOQ strategies that allow brands to test market reception without committing to excessive inventory. [zhenyibio]
- High communication efficiency and OEM/ODM depth
The company supports end-to-end OEM/ODM services for cosmetic raw materials and semi-finished products, including formulation advice, technical documentation, and basic regulatory guidance for export markets, streamlining product launch timelines for overseas clients. [fdichina]
This positioning makes ZHENYIBIO a high-value, cost-effective choice for global cosmetic brands that require plant-based liposomal actives and want closer technical collaboration rather than purely transactional raw material supply. [yicaiglobal]
Xi'an SOST Biotech positions itself as a leading supplier of nanoliposome raw materials for functional foods, nutraceuticals, and cosmetics, with a strong focus on liposomal glutathione and resveratrol. The company deploys a microfluidic chip nanoreactor system plus high-pressure homogenization, achieving particle sizes typically between 50–200 nm with PDI below 0.1, and reports encapsulation efficiencies above 95% and bioavailability improvements of 8–10 times versus conventional powders. [sostapi]
Its production base integrates TEM analysis, zeta potential testing, and HPLC-MS quantification, and each batch is accompanied by NTA-based particle size and stability reports consistent with dietary supplement cGMP expectations. SOST holds ISO 9001, HALAL, and KOSHER certifications and offers OEM support to nutritional brands worldwide, making it suitable for buyers seeking nutraceutical-grade liposome ingredients at scale. [sostapi]
Natural Field is a liposomal manufacturer focused on nutritional supplements, with more than 20 years of experience and over 39 national patents. Its liposomal portfolio covers glutathione, CoQ10, curcumin, NMN, and other bioactives, leveraging non-GMO sunflower lecithin, GMP-certified production, and certifications such as FSSC 22000 and HACCP for global food safety compliance. [naturalfieldinc]
The company emphasizes uniform particle size distribution and stable liposome structures, which are critical for consistent bioavailability and shelf-life performance in oral formats like powders and liquids. For international buyers, Natural Field's combination of patent-backed encapsulation technology and broad nutraceutical product range makes it a solid option for diversified liposomal ingredient sourcing. [naturalfieldinc]
Shanghai Nano Pharmaceutical Technology focuses on injectable liposome formulations, leveraging the innovation resources of Shanghai's Zhangjiang Pharmaceutical Valley. The company concentrates on anti-tumor drug carriers and advanced injectable delivery systems, benefiting from proximity to major hospitals, CROs, and academic institutions. [sostapi]
Thanks to this high-end positioning, it is particularly suitable for pharma or advanced dermocosmetic brands that require clinical-grade or near-clinical-grade liposomal delivery platforms, including PEGylated systems and controlled-release technologies. However, MOQs and technical requirements are typically more demanding compared to purely cosmetic ingredient vendors, which buyers need to account for in project planning. [naturalfieldinc]
Jiangsu Ailicon has a long history in phospholipid manufacturing and has extended its portfolio into liposome membrane materials like lecithin and hydrogenated phospholipids. This upstream positioning allows Ailicon to offer tight cost control and raw material continuity, which is crucial for large-scale liposome production where lipid quality directly impacts performance and regulatory acceptance. [sostapi]
The company's core advantage lies in supplying high-purity phospholipids and membrane materials to downstream liposome manufacturers, contributing to standardized formulation inputs. Buyers engaged in in-house liposome production or looking to diversify their phospholipid sources can consider Ailicon as a strategic raw material partner. [sostapi]
Guangzhou Tianrun operates as a major supplier of liposomal vitamin C, curcumin, and related products, widely used in food, beverage, and functional health markets. Located in South China's vibrant manufacturing belt, the company emphasizes rapid prototyping and flexible production capabilities, which are particularly helpful for brands testing new liposomal formulations or seasonal SKUs. [sostapi]
Its product mix and regional logistics make it attractive to buyers in Asia-Pacific seeking shorter lead times and agile response to formulation adjustments or regulatory feedback. For those targeting mass-market functional beverages or nutricosmetics, Tianrun offers a balance of scale and responsiveness. [sostapi]
Hisun Pharmaceutical is a well-established pharma group that develops complex injectable formulations, including liposomal doxorubicin and other oncology drugs. The API division's experience in injectable liposomes and conjugated systems makes it suitable for customers requiring pharmaceutical-grade liposome process transfer or co-development, particularly in generic or specialty injectable pipelines. [naturalfieldinc]
Because its main business is regulated pharmaceuticals, Hisun's QC systems, validation frameworks, and regulatory documentation tend to align with stringent authorities, which may be over-specified for cosmetic-only projects but ideal for high-risk therapeutic applications. Buyers should be prepared for higher MOQs and longer development cycles when engaging in such complex projects. [coherentmarketinsights]
Fudan-Zhangjiang is known for developing China's first PEGylated liposomal doxorubicin injection (LIBOd), approved since 2009 for indications such as sarcoma and ovarian cancer. This milestone reflects deep expertise in PEGylated liposome design, extended circulation time, and the enhanced permeability and retention (EPR) effect critical to oncology drug delivery. [naturalfieldinc]
For buyers focused on high-end drug delivery R&D, Fudan-Zhangjiang's experience with regulatory approvals and clinical pipelines offers a strong basis for co-development or licensing discussions. However, this profile is more aligned with clinical and hospital-use products than with general cosmetic ingredients. [coherentmarketinsights]
BOCSCI provides custom liposome and lipid nanoparticle formulation services, serving preclinical and clinical studies for RNA, DNA, peptide, and small molecule delivery. Its services are particularly relevant for biotech firms and advanced cosmetic brands that want tailor-made carriers for specific actives, rather than off-the-shelf liposomal powders. [naturalfieldinc]
Innobio, by contrast, offers the Durlip liposome technology for nutraceuticals, focusing on improved absorption of vitamins and minerals. Together, they represent a service-oriented segment of China's liposome industry, where formulation design and delivery optimization are core value propositions rather than commodity manufacturing alone. [naturalfieldinc]
Several emerging players underscore the breadth of China's liposome ecosystem:
- Chengdu NovoShengtai Biopharmaceutical
Develops microfluidic liposome equipment and offers integrated CRO/CDMO services, emphasizing fast response and tailored projects, suitable for agile R&D programs. [sostapi]
- Suzhou Nanomicro Technology
Focuses on chromatographic media and particle size sieving technologies that are critical for liposome purification and size control, providing tools and media to other manufacturers rather than finished liposomal products. [sostapi]
- Tianjin Jinyao Ruida Biotechnology
Holds patents in liposome vaccine adjuvants and gained visibility during the COVID-19 period, illustrating how vaccine-focused liposome technology can spill over into broader drug delivery innovation. [sostapi]
These companies may not all be direct suppliers of cosmetic liposomal actives but are important technical partners in the supply chain, especially for buyers pursuing co-development of complex delivery systems. [sostapi]
Below is a simplified comparison to help procurement managers match suppliers with project profiles. Values are indicative and based on public disclosures and typical positioning; specific figures should be verified directly with each manufacturer. [coherentmarketinsights]
Table: Representative Profiles of Chinese Liposome Manufacturers
Manufacturer | Typical Segment Focus | Relative Capacity Level | Typical MOQ Range (indicative) | Key Certifications / Standards (indicative) |
|---|---|---|---|---|
ZHENYIBIO TECHNOLOGY INC | Cosmetic plant liposomal actives | Medium | Low to medium (flexible) | Cosmetic QMS, export-ready documents zhenyibio |
Xi’an SOST Biotech | Nutraceutical liposomal actives | High | Medium to high | ISO 9001, HALAL, KOSHER, cGMP-like dietary sostapi |
Xi’an Natural Field | Liposomal nutraceuticals | High | Medium | GMP, FSSC 22000, HACCP naturalfieldinc |
Shanghai Nano Pharmaceutical | Injectable liposomes | Medium | High | Pharma-grade GMP, clinical alignment sostapi |
Jiangsu Ailicon | Phospholipids / membrane | High | High (bulk raw) | ISO-based QMS, pharma-linked sostapi |
Guangzhou Tianrun | Liposomal VC & curcumin | Medium to high | Medium | Food-grade GMP regionally sostapi |
Zhejiang Hisun (API) | Injectable oncology liposomes | High | High | Pharma GMP, regulatory approvals sostapi |
Fudan-Zhangjiang | PEGylated liposomal doxorubicin | Medium | High | NMPA-approved injectable, PEGylated tech naturalfieldinc |
BOCSCI / Innobio | Custom LNP / nutraceuticals | Project-based | Project-specific | GLP/GMP-linked services, nutraceutical refs naturalfieldinc |
Chengdu NovoShengtai / others | CDMO & equipment | Project-based | Project-specific | CRO/CDMO QA systems sostapi |
This table is intended as a directional guide; actual capacity, MOQs, and certification portfolios should be verified against up-to-date factory documentation during supplier qualification. [naturalfieldinc]
Beyond commercial metrics, procurement managers should pay close attention to the technical profile of liposome-based ingredients, especially when dealing with actives sensitive to oxidation, light, or pH. [sciencedirect]
Key technical factors include:
- Material grade and lipid selection
Many Chinese suppliers utilize non-GMO sunflower or soybean phospholipids, often hydrogenated for improved stability; buyers should request phospholipid specifications (acid value, peroxide value, phosphatidylcholine content) to ensure compatibility with intended applications. [sciencedirect]
- Process technology and particle size distribution
Advanced methods such as microfluidics and controlled high-pressure homogenization yield narrow particle size distributions (e.g., 50–200 nm with low PDI), which improve bioavailability, skin penetration, and product stability compared with conventional thin-film hydration alone. [sciencedirect]
- Encapsulation efficiency and release profile
Suppliers like SOST explicitly present encapsulation efficiency above 95% and sustained release curves (e.g., 85% release after 4 hours in simulated conditions), metrics that help brands translate technical performance into marketing claims while staying evidence-based. [pmc.ncbi.nlm.nih]
- Regulatory and environmental certifications
For cosmetic raw materials, buyers increasingly look for ISO 16128-compliant natural index calculations and ECOCERT-compatible raw material verification to support clean-label or natural-origin claims. [ecocert]
Despite the maturity of China's liposome ecosystem, international buyers still face recurring pitfalls when sourcing liposomal ingredients and OEM/ODM services. [fdichina]
Typical pain points include:
- Substitution of lipid or active quality
Some lower-tier suppliers may replace specified phospholipids or active concentrations with cheaper alternatives, leading to lower encapsulation efficiency, off-spec particle size, or shortened shelf life; this may only become evident after stability testing. [pmc.ncbi.nlm.nih]
- Inconsistent batch performance
Inadequate control of process parameters (temperature, shear, hydration time) can cause wide PDI variation, aggregation, or phase separation, undermining the consistency needed for regulatory submissions and global distribution. [pmc.ncbi.nlm.nih]
- Overstated capacity or regulatory readiness
A factory might list multiple certifications or high annual capacity on marketing materials while lacking robust in-house QC or relying heavily on external labs, which can complicate long-term supply and regulatory audits. [fdichina]
- Documentation gaps
Missing or incomplete COAs, TDS, stability data, or safety assessments (e.g., microbial limits, heavy metals, residual solvents) can delay product registrations and increase compliance risk in markets with stringent cosmetic or nutraceutical regulations. [fdichina]
Within the industry, experienced buyers often share informal "red-flag" criteria that rarely appear in polished marketing materials but are extremely useful in practice. [xiaoyuzhoufm]
One widely acknowledged yet seldom written rule is: always compare how the factory responds when you ask for worst-case data—such as failed-batch reports, deviation logs, or stability results that did not meet specifications. Suppliers truly confident in their systems typically can show anonymized deviation trends, explain root causes, and present corrective actions, whereas weaker vendors may avoid the topic, claim such issues never happen, or send incomplete records, which is itself a red flag. [xiaoyuzhoufm]
Another implicit rule is to check whether the liposome supplier can explain how its delivery system interacts with common cosmetic bases (e.g., high ethanol, high electrolyte, or surfactant-rich systems); a factory that cannot discuss such compatibility beyond generic claims often lacks real application insight. These qualitative checks, combined with quantitative QC data, significantly reduce the risk of "black-box" suppliers. [xiaoyuzhoufm]
A structured procurement process helps mitigate risks, especially when dealing with complex delivery systems like liposomes in global cosmetic or nutraceutical markets. [fdichina]
- Request full documentation package
At minimum, ask for COA, TDS, MSDS, process flow overview, and stability data (e.g., 6–12 months accelerated tests), plus any ISO, GMP, HALAL, KOSHER, or raw material verification (such as ISO 16128). [ecocert]
- Cross-check certifications
Most ISO certificates include a validity date and certification body; procurement teams should directly verify certificate numbers on the certifier's website or via email to ensure they are active and applicable to relevant product categories. [ecocert]
- Assess regulatory readiness
For cosmetics entering China or other regulated markets, coordinate with regulatory consultants or local partners familiar with cosmetic registration or filing requirements. [fdichina]
- Multi-batch sampling
Instead of relying on a single sample, request multiple trial batches or at least two independent lots to assess consistency in particle size, encapsulation efficiency, and key QC parameters. [sciencedirect]
- Formulation and stress testing
Evaluate performance under typical stress conditions—heat–cold cycles, high-shear mixing, and pH adjustment—within your specific formulation base, particularly for alcohol-containing or surfactant-rich systems. [pmc.ncbi.nlm.nih]
- Application fit
For cosmetic applications, check how the liposomal ingredient impacts sensorial properties (viscosity, clarity, color, odor) and whether it interacts with preservatives, chelating agents, or emulsifiers. [xiaoyuzhoufm]
- Clearly define specifications
Set explicit specifications for particle size, PDI, encapsulation efficiency, active content, and microbial/impurity limits, including acceptable ranges and testing methods, in your supply agreement. [pmc.ncbi.nlm.nih]
- Lead times and safety stock
Discuss standard lead times and agree on safety stock strategies; some manufacturers can hold buffer stock for key customers to absorb demand spikes or logistics delays. [yicaiglobal]
- Packaging and transport
For liposomal powders or liquids, ensure packaging is suited to preventing oxidation, moisture ingress, or temperature excursions; temperature-controlled shipping may be necessary for highly sensitive actives. [pmc.ncbi.nlm.nih]
China's liposome manufacturing ecosystem now spans pharmaceutical injectables, nutraceuticals, and cosmetic actives, giving global buyers a wide choice of partners—from large pharma-oriented CDMOs to flexible, R&D-driven cosmetic ingredient specialists like ZHENYIBIO TECHNOLOGY INC. By combining structured evaluation criteria, robust documentation checks, and practical "insider" red flags, procurement managers can significantly reduce risk and build long-term, mutually beneficial relationships with Chinese liposome suppliers. [zhenyibio]
If you are a cosmetic or nutraceutical brand seeking plant-based, science-backed liposomal actives with flexible MOQs and strong OEM/ODM support, engaging with a mid-sized, R&D-focused supplier such as ZHENYIBIO can be a pragmatic next step—starting with technical discussions, sample evaluations, and a pilot project. [zhenyibio]
1. How can I verify whether a supplier's ISO certification is still valid?
Ask for the latest scanned certificate with number and issuing body, then verify directly on the certification body's website or directory; many ISO and accreditation bodies provide searchable databases where you can confirm scope, validity period, and site coverage. [ecocert]
2. What is a reasonable PDI and particle size range for cosmetic liposome ingredients?
For many cosmetic and nutraceutical applications, liposome particle sizes between about 50–200 nm with a PDI below around 0.2 are considered acceptable, though best-in-class suppliers may report PDI below 0.1 and very narrow distributions; exact targets depend on the active and delivery goals. [sciencedirect]
3. How do I detect if a supplier has downgraded phospholipids or actives without disclosure?
Beyond COAs, independent lab testing (HPLC/LC-MS for active content, phospholipid composition analysis, oxidation indicators) on random batches can reveal substitution or degradation; consistent supplier transparency about deviations and third-party testing is another critical indicator. [pmc.ncbi.nlm.nih]
4. Are food-grade liposomal ingredients always suitable for cosmetic applications?
Not necessarily; while food-grade standards often exceed basic safety requirements, cosmetic formulations may introduce other compatibility constraints (e.g., high surfactant content or solvents) and require different preservative strategies and stability testing, so cross-application must be validated case by case. [fdichina]
5. How should I evaluate OEM/ODM partners for liposomal cosmetics?
Beyond raw ingredient quality, assess their formulation support capabilities, pilot facilities, clinical or instrumental testing experience (e.g., skin penetration, irritation testing), and ability to provide regulatory documentation tailored to your target markets. [xiaoyuzhoufm]
- Natural Field – Top 10 Liposomal Manufacturers in China (industry overview and company profiles) [naturalfieldinc]
- SOST Biotech – China's Top 10 Liposome Suppliers and nanoliposome technology discussion [sostapi]
- Liposomes Market Reports – Coherent Market Insights and Cognitive Market Research (market size and forecasts) [cognitivemarketresearch]
- Scientific Reviews on Liposomes – Production methods and drug delivery performance [sciencedirect]
- Raw Material Verification – ISO 16128 and ECOCERT guidance for natural cosmetic ingredients [ecocert]
- China Cosmetics Export and Market Data – China Customs and industry analyses [entercogroup]
- Regulatory Guides – Cosmetics registration and compliance procedures for China and export markets [fdichina]